| This paper describes pharmacometric research of ManNAc administration in patients with GNE myopathy, a rare genetic muscle disease. |
| The population pharmacokinetic model presented provides a useful tool in the clinical drug development of ManNAc to guide dose selection and understand the effects of oral ManNAc administration on Neu5Ac production and exposure. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.